IRMD (STOCKS)
iRadimed Corporation
$105.100000
+2.020000 (+1.96%)
Prev close: $103.080000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Roger Susi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,464.88M
- Employees
- 160
- P/E (TTM)
- 58.90
- P/B (TTM)
- 13.33
- Dividend Yield
- 65.97%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $80.51M |
| Benefits Costs and Expenses | $53.60M |
| Cost Of Revenue | $18.46M |
| Costs And Expenses | $53.60M |
| Gross Profit | $62.05M |
| Nonoperating Income/Loss | $2.06M |
| Operating Expenses | $37.20M |
| Research and Development | $2.75M |
| Other Operating Expenses | $34.45M |
| Operating Income/Loss | $24.85M |
| Income/Loss From Continuing Operations After Tax | $21.18M |
| Income/Loss From Continuing Operations Before Tax | $26.91M |
| Income Tax Expense/Benefit | $5.73M |
| Net Income/Loss | $21.18M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $21.18M |
| Net Income/Loss Available To Common Stockholders, Basic | $21.18M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.67 |
| Diluted Earnings Per Share | $1.65 |
| Basic Average Shares | 38,155,381 |
| Diluted Average Shares | 38,542,369 |
| Assets | $114.72M |
| Current Assets | $84.92M |
| Inventory | $11.73M |
| Other Current Assets | $73.18M |
| Noncurrent Assets | $29.80M |
| Fixed Assets | $23.79M |
| Other Non-current Assets | $6.01M |
| Liabilities | $16.37M |
| Current Liabilities | $12.80M |
| Accounts Payable | $2.33M |
| Wages | $4.07M |
| Other Current Liabilities | $6.39M |
| Noncurrent Liabilities | $3.57M |
| Equity | $98.35M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $98.35M |
| Liabilities And Equity | $114.72M |
| Net Cash Flow From Operating Activities | $25.01M |
| Net Cash Flow From Operating Activities, Continuing | $25.01M |
| Net Cash Flow From Investing Activities | -$11.06M |
| Net Cash Flow From Investing Activities, Continuing | -$11.06M |
| Net Cash Flow From Financing Activities | -$9.15M |
| Net Cash Flow From Financing Activities, Continuing | -$9.15M |
| Net Cash Flow | $4.81M |
| Net Cash Flow, Continuing | $4.81M |
| Comprehensive Income/Loss | $21.18M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $21.18M |
| Other Comprehensive Income/Loss | $0.00 |